Amino heterocyclic modulators of chemokine receptor activity

Details for Australian Patent Application No. 2005214319 (hide)

Owner Merck & Co., Inc.

Inventors Yang, Lihu; Pasternak, Alexander; Mills, Sander G.

Agent Spruson & Ferguson

Pub. Number AU-B-2005214319

PCT Pub. Number WO2005/080371

Priority 60/544,763 12.02.04 US

Filing date 8 February 2005

Wipo publication date 1 September 2005

Acceptance publication date 19 February 2009

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/47 (2006.01) - Quinolines

C07D 207/12 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/16 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 215/14 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 307/24 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/02 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 471/02 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

7 September 2006 PCT application entered the National Phase

  PCT publication WO2005/080371 Priority application(s): WO2005/080371

19 February 2009 Application Accepted

  Published as AU-B-2005214319

18 June 2009 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

1 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005214322-Hyphal growth in fungi

2005214316-Impact-modified compositions and method